Our experienced leadership team has carved a path over decades of academic and industry roles. At Onchilles, we are developing novel drugs leveraging new neutrophil and macrophage biology to induce apoptosis in cancer cells. We are motivated to confront unmet medical needs in the world with novel and compelling science.